Gallium-68 PET: A Powerful Generator-based Alternative to Infection and Inflammation Imaging

Seminars in Nuclear Medicine

Volumn 46, Issue 5, 2016, Pages 436-447

  Vorster, Mariza ^a   Maes, Alex ^a   Wiele, Christophe van de ^a   Sathekge, Mike ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM 68; GALLIUM;

ABDOMINAL INFECTION; ALZHEIMER DISEASE; ANGIOGENESIS; ARTHRITIS; ASPERGILLOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHLAMYDIA MURIDARUM; CHLAMYDIASIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; GASTROINTESTINAL DISEASE; HUMAN; HYPOXIA; IMMUNE RESPONSE; INFECTION; INFLAMMATION; LUNG FIBROSIS; MYOCARDITIS; NECROSIS; NONHUMAN; OPPORTUNISTIC INFECTION; OSTEOMYELITIS; PATHOPHYSIOLOGY; PRECLINICAL STUDY; PREDICTIVE VALUE; REVIEW; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; SYNOVITIS; THROMBOCYTE FUNCTION; THROMBUS; TREATMENT RESPONSE; TUBERCULOSIS; ANIMAL; DIAGNOSTIC IMAGING; POSITRON EMISSION TOMOGRAPHY; PROCEDURES;

ANIMALS; GALLIUM RADIOISOTOPES; HUMANS; INFECTION; INFLAMMATION; POSITRON-EMISSION TOMOGRAPHY;

EID: 84983081937     PISSN: 00012998     EISSN: 15584623     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2016.04.005     Document Type: Review

References (42)

1. 1 Eggleston, H., Panizzi, P., Molecular imaging of bacterial infections in vivo: The discrimination between infection and inflammation. Informatics 1:1 (2014), 72–99.
2. 2 Jalilian, A.R., An overview on Ga-68 radiopharmaceuticals for positron emission tomography applications. Iran J Nucl Med 24:1 (2016), 1–10.
3. 3 Kilian, K., 68Ga-DOTA and analogs: Current status and future perspectives. Rep Prac Oncol and Radiother 19 (2014), S13–S21.
4. 4 Ebenhan, T., Chadwick, N., Sathekge, M.M., et al. Peptide synthesis, characterization and 68Ga-radiolabeling of NOTA-conjugated ubiquicidin fragments for prospective infection imaging with PET/CT. Nucl Med Biol 41:5 (2014), 390–400.
5. 5 Vorster, M., Mokaleng, B., Sathekge, M.M., Ebenhan, T., A modified technique for efficient radiolabeling of 68Ga-citrate from a SnO2-based 68Ge/68Ga generator for better infection imaging. Hell J Nucl Med 16:3 (2013), 193–198.
6. 6 AWJM, Glaudemans, Israel, O., RHJA, Slart, Pitfalls and limitations of radionuclide and hybrid imaging in infection and inflammation. Semin Nucl Med 45:6 (2015), 500–512.
7. 7 Palestro, C.J., The current role of gallium imaging in infection. Semin Nucl Med 24:2 (1994), 128–141.
8. 8 Vorster, M., Maes, A., Van de Wiele, C., et al. Gallium-68: a systematic review of its nononcological applications. Nucl Med Commun 34:9 (2013), 834–854.
9. 9 Satpati, D., Arjun, C., Krishnamohan, R., et al. (68) Ga-labeled ciprofloxacin conjugates as radiotracers for targeting bacterial infection. Chem Biol Drug Des 87:5 (2016), 680–686.
10. 10 Mokaleng, B.B., Ebenhan, T., Ramesh, S., et al. Synthesis, 68Ga-radiolabeling, and preliminary in vivo assessment of a depsipeptide-derived compound as a potential PET/CT infection imaging agent. BioMed Research Int, 2015(6), 2015, 284354.
11. 11 Welling, M.M., Bunschoten, A., Kuil, J., et al. Development of a hybrid tracer for SPECT and optical imaging of bacterial infections. Bioconjug Chem 26:5 (2015), 839–849.
12. 12 Petrik, M., Zhai, C., Novy, Z., et al. In vitro and in vivo comparison of selected Ga-68 and Zr-89 labelled siderophores. Mol Imaging Biol, 2015: 30 [Epub ahead of print].
13. 13 Lankinen, P., Mäkinen, T.J., Pöyhönen, T.A., et al. 68Ga-DOTAVAP-P1 PET imaging capable of demonstrating the phase of inflammation in healing bones and the progress of infection in osteomyelitic bones. Eur J Nucl Med Mol Imaging 35:2 (2008), 352–364.
14. 14 Kumar, V., Boddeti, D.K., Evans, S.G., et al. Potential use of 68Ga-apo-transferrin as a PET imaging agent for detecting Staphylococcus aureus infection. Nucl Med Biol 38:3 (2011), 393–398.
15. 15 Nanni, C., Errani, C., Boriani, L., et al. 68Ga-citrate PET/CT for evaluating patients with infections of the bone: Preliminary results. J Nucl Med 51:12 (2010), 1932–1936.
16. 16 Jalkanen, S., Salmi, M., VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation. Arterioscler Thromb Vasc Biol 28:1 (2008), 18–26.
17. 17 Paulos, C.M., Turk, M.J., Breur, G.J., Low, P.S., Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv Drug Deliv Rev 56:8 (2004), 1205–1217.
18. 18 Low, P.S., Antony, A.C., Folate receptor-targeted drugs for cancer and inflammatory diseases. Adv Drug Deliv Rev 56:8 (2004), 1055–1058.
19. 19 Xia, W., Hilgenbrink, A.R., Matteson, E.L., et al. A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood 113:2 (2009), 438–446.
20. 20 Morris, E., Chalkidou, A., Hammers, A., et al. Diagnostic accuracy of 18F amyloid PET tracers for the diagnosis of Alzheimer's disease: A systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 43:2 (2015), 374–385.
21. 21 McConathy, J., Sheline, Y.I., Imaging biomarkers associated with cognitive decline: A review. Biological Psychiatry 77:8 (2015), 685–692.
22. 22 Watanabe, H., Ono, M., Iikuni, S., et al. A 68Ga complex based on benzofuran scaffold for the detection of β-amyloid plaques. Bioorg Med Chem Lett 24:20 (2014), 4834–4837.
23. 23 Li, X., Bauer, W., Israel, I., et al. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: Correlation with in vivo 17.6T MRI. Arterioscler Thromb Vasc Biol 34:8 (2014), 1661–1667.
24. 24 Caforio, A.L.P., Marcolongo, R., Jahns, R., et al. Immune-mediated and autoimmune myocarditis: Clinical presentation, diagnosis and management. Heart Fail Rev 18:6 (2012), 715–732.
25. 25 Eo, J.S., Paeng, J.C., Lee, S., et al. Angiogenesis imaging in myocardial infarction using 68Ga-NOTA-RGD PET. Coron Artery Dis 24:4 (2013), 303–311.
26. 26 Kiugel, M., Dijkgraaf, I., Kytö, V., et al. Dimeric [68Ga]DOTA-RGD peptide targeting αvβ3 integrin reveals extracellular matrix alterations after myocardial infarction. Mol Imaging Biol 16:6 (2014), 793–801.
27. 27 Haukkala, J., Laitinen, I., Luoto, P., et al. 68Ga-DOTA-RGD peptide: Biodistribution and binding into atherosclerotic plaques in mice. Eur J Nucl Med Mol Imaging 36:12 (2009), 2058–2067.
28. 28 Silvola, J., Autio, A., Luoto, P., et al. Preliminary evaluation of novel 68Ga-DOTAVAP-PEG-P2 peptide targeting vascular adhesion protein-1. Clin Physiol Funct Imaging 30:1 (2010), 75–78.
29. 29 Silvola, J.M., Laitinen, I., Sipilä, H.J., et al. Uptake of 68gallium in atherosclerotic plaques in LDLR-/-ApoB100/100 mice. EJNMMI Res, 1(1), 2011, 14.
30. 30 Autio, A., Henttinen, T., Sipilä, H.J., et al. Mini-PEG spacering of VAP-1-targeting 68Ga-DOTAVAP-P1 peptide improves PET imaging of inflammation. EJNMMI Res 1:1 (2011), 10–17.
31. 31 Thackeray, J.T., Bankstahl, J.P., Wang, Y., et al. Targeting post-infarct inflammation by PET imaging: Comparison of 68Ga-citrate and 68Ga-DOTATATE with 18F-FDG in a mouse model. Eur J Nucl Med Mol Imaging 42:2 (2014), 317–327.
32. 32 Zhou, J., Hao, G., Weng, H., et al. In vivo evaluation of medical device-associated inflammation using a macrophage-specific positron emission tomography (PET) imaging probe. Bioorg Med Chem Lett 23:7 (2013), 2044–2047.
33. 33 Prinsen, K., Cona, M.M., Cleynhens, B.J., et al. Synthesis and biological evaluation of 68Ga-bis-DOTA-PA as a potential agent for positron emission tomography imaging of necrosis. Nucl Med Biol 40:6 (2013), 816–822.
34. 34 Virtanen, H., Autio, A., Siitonen, R., et al. 68Ga-DOTA-Siglec-9 – a new imaging tool to detect synovitis. Arthritis Res Ther 17:1 (2015), 1–11.
35. 35 Eichendorff, S., Svendsen, P., Bender, D., et al. Biodistribution and PET imaging of a novel [68Ga]-anti-CD163-antibody conjugate in rats with collagen-induced arthritis and in controls. Mol Imaging Biol 17:1 (2014), 87–93.
36. 36 Choi, H., Phi, J.H., Paeng, et al. Imaging of integrin a (V) B (3) expression using (68) Ga-RGD positron emission tomography in pediatric cerebral infarct. Mol Imaging 12:4 (2013), 213–217.
37. 37 Rominger, A., Saam, T., Vogl, E., et al. In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET/CT: Correlation with coronary calcium burden and risk factors. J Nucl Med 51:2 (2010), 193–197.
38. 38 Lapa, C., Reiter, T., Li, X., et al. Imaging of myocardial inflammation with somatostatin receptor based PET/CT — A comparison to cardiac MRI. Int J Cardiol 194:C (2015), 44–49.
39. 39 Vorster, M., Maes, A., Jacobs, A., et al. Evaluating the possible role of 68Ga-citrate PET/CT in the characterization of indeterminate lung lesions. Ann Nucl Med 28:6 (2014), 523–530.
40. 40 Ambrosini, V., Zompatori, M., De Luca, F., et al. 68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: Preliminary results. J Nucl Med. 51:12 (2010), 1950–1955.
41. 41 Soydal, C., Kucuk, O.N., Ozkan, E., et al. Ga-68 DOTATATE accumulation in sarcoidosis. Int J Nucl Med Res 2:2 (2015), 1–4.
42. 42 Rizzello, A., Di Pierro, D., Lodi, F., et al. Synthesis and quality control of 68Ga citrate for routine clinical PET. Nucl Med Commun 30:7 (2009), 542–545.